Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Donor XCR1 + and CD11b + Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract

Motoko Koyama, Shuichiro Takahashi, Takayuki Inoue, Kathleen S Ensbey, Samuel R. W. Legg, Tomoko Sekiguchi, Ethan Nelson, Nicole S Nemychenkov, Tanvi Joshi, Simone A Minnie, Albert C Yeh, Julie R Boiko, Ping Zhang, Mark B Headley, Jisun Paik, John K Amory, Geoffrey R. Hill

Blood (2024) 144 (Supplement 1): 905.

https://doi.org/10.1182/blood-2024-209473

Published: 2024

Journal Articles

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Julie R. Boiko, MS, Annie Im, MD, Xiaohua Chen, MDPhD, Memphis J Hill, BS, Paul Szabolcs, MD

Blood (2015) 126 (23): 1932.

https://doi.org/10.1182/blood.V126.23.1932.1932

Published: 2015

Journal Articles

Portomesenteric Venous Thrombosis As First Presentation of Thrombophilic Disorders in Adolescents

Julie R. Boiko, MS, James D. Cooper, MD

Blood (2014) 124 (21): 5073.

https://doi.org/10.1182/blood.V124.21.5073.5073

Published: 2014

Journal Articles

IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation

Julie R. Boiko, Bita Sahaf, PhD, Antonia M.S. Mueller, MD, George L. Chen, MD, Dolly Tyan, PhD, David B. Miklos, MD, PhD

Blood (2008) 112 (11): 349.

https://doi.org/10.1182/blood.V112.11.349.349

Published: 2008

Journal Articles

Rituximab Infusion Two Months after HCT Decreases Alloreactive B Cell Responses While Recipient Plasma Cells Persist.

Bi ta Sahaf, PhD, Julie R. Boiko, George Chen, MD, Kartoosh Heydari, MD, Sally Arai, MD, David Miklos, MD, PhD

Blood (2008) 112 (11): 2234.

https://doi.org/10.1182/blood.V112.11.2234.2234

Published: 2008

Journal Articles

Allotype Reagents Distinguish Donor and Recipient Antibodies after Hematopoietic Transplantation.

Julie R. Boiko, Bita Sahaf, PhD, David B. Miklos, MD/PhD

Blood (2006) 108 (11): 2906.

https://doi.org/10.1182/blood.V108.11.2906.2906

Published: 2006

NARROW

Donor XCR1 + and CD11b + Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Portomesenteric Venous Thrombosis As First Presentation of Thrombophilic Disorders in Adolescents

IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation

Rituximab Infusion Two Months after HCT Decreases Alloreactive B Cell Responses While Recipient Plasma Cells Persist.

Allotype Reagents Distinguish Donor and Recipient Antibodies after Hematopoietic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Donor XCR1 + and CD11b + Dendritic Cells Determine the Severity of Th1 and Th17-Dependent Acute Gvhd within the Gastrointestinal Tract

Characterization of Regulatory T Cell Reconstitution after Allogeneic Hematopoietic Cell Transplantation: Expansion Potential at 100 Days Predicts De Novo Graft-Versus-Host Disease By Six Months Post-Transplantation

Portomesenteric Venous Thrombosis As First Presentation of Thrombophilic Disorders in Adolescents

IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation

Rituximab Infusion Two Months after HCT Decreases Alloreactive B Cell Responses While Recipient Plasma Cells Persist.

Allotype Reagents Distinguish Donor and Recipient Antibodies after Hematopoietic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only